Rockwell Medical (RMTI) Net Cash Flow Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -62.71% |
| 10 | Rockwell Medical | 28.09 Mn | 4.20 Mn | 2.90 Mn | -50.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.78% |
| Dec 31, 2025 | -0.71% |
| Sep 30, 2025 | 27.26% |
| Jun 30, 2025 | -62.12% |
| Mar 31, 2025 | -8.27% |
| Dec 31, 2024 | 32.55% |
| Sep 30, 2024 | 27.09% |
| Jun 30, 2024 | 53.04% |
| Mar 31, 2024 | 43.54% |
| Dec 31, 2023 | 29.15% |
| Sep 30, 2023 | -26.83% |
| Jun 30, 2023 | 43.46% |
| Mar 31, 2023 | -68.57% |
| Dec 31, 2022 | -3.10% |
| Sep 30, 2022 | -36.52% |
| Jun 30, 2022 | 247.42% |
| Mar 31, 2022 | -23.32% |
| Dec 31, 2021 | -36.60% |
| Sep 30, 2021 | -76.84% |
| Jun 30, 2021 | -29.17% |